ImmuCell Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.81	3.76	0.98	5.79	10.19
Cash & Short-Term Investments	3.81	3.76	0.98	5.79	10.19
Cash Growth	1.29%	283.99%	-83.10%	-43.14%	28.18%
Accounts Receivable	3.42	3.77	2.19	1.76	2.69
Inventory	9.27	7.11	7.81	6.04	3.09
Other Current Assets	0.45	0.4	0.49	0.41	0.3
Total Current Assets	16.94	15.04	11.47	13.99	16.26
Net Property, Plant & Equipment	25.45	29.91	32.15	30.64	28
Other Intangible Assets	-	0.02	0.04	0.06	0.08
Goodwill	0.1	0.1	0.1	0.1	0.1
Other Long-Term Assets	0.04	0.03	0.06	0.08	0.03
Total Assets	42.53	45.1	43.81	44.86	44.47
Accounts Payable	2.28	2.48	2.12	2	1.61
Current Portion of Long-Term Debt	1.61	1.5	1.43	1.04	0.81
Current Portion of Leases	0.09	0.43	0.64	0.03	0.11
Total Current Liabilities	3.98	4.41	4.2	3.07	2.53
Long-Term Debt	7.49	9.04	10.54	9.19	8.33
Long-Term Leases	4.01	4.13	4.08	2.22	1.03
Total Long-Term Liabilities	11.5	13.17	14.62	11.41	9.35
Total Liabilities	15.48	17.58	18.82	14.48	11.89
Common Stock	0.91	0.9	0.78	0.78	0.78
Treasury Stock	-0.13	-0.14	-0.14	-0.15	-0.16
Additional Paid-in Capital	41.48	40.92	36.36	35.98	35.69
Retained Earnings	-15.2	-14.16	-12.01	-6.23	-3.74
Shareholders' Equity	27.06	27.52	24.99	30.38	32.58
Total Liabilities & Equity	42.53	45.1	43.81	44.86	44.47
Total Debt	13.19	15.1	16.69	12.48	10.27
Net Cash (Debt)	-9.39	-11.34	-15.71	-6.69	-0.09
Net Cash Per Share	-1.04	-1.39	-2.03	-0.86	-0.01
Book Value	27.06	27.52	24.99	30.38	32.58
Book Value Per Share	3.00	3.37	3.23	3.92	4.29
Tangible Book Value	26.96	27.4	24.86	30.23	32.4
Tangible Book Value Per Share	2.99	3.36	3.21	3.90	4.27

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q